Deal Watch: BMS Licenses Bispecific TCR Candidate From Immatics
Executive Summary
BioMarin teams with Skyline on gene therapies for cardiovascular disease. Myrtelle discloses licensing of gene therapy for Canavan disease from Pfizer earlier in 2021.